Actively Recruiting

Phase 2
Age: 40Years - 80Years
All Genders
NCT07016412

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

Led by Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA · Updated on 2026-05-13

480

Participants Needed

55

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to placebo and to the individual components of the fixed dose combinations, each administered twice a day via standard jet nebulizer, in adult subjects with chronic obstructive pulmonary disease (COPD).

CONDITIONS

Official Title

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

Who Can Participate

Age: 40Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male participants must agree to use contraception or abstinence and not donate fresh unwashed semen during the study and for 30 days after
  • Female participants must not be pregnant or breastfeeding and either not be of childbearing potential or agree to contraceptive guidance and not donate eggs during the study and for 30 days after
  • Current or former cigarette smokers with at least 10 pack years smoking history
  • History of COPD as defined by ATS/ERS guidelines with compatible symptoms
  • Dyspnea score of 2 or higher on the Modified Medical Research Council (mMRC) scale at screening
  • Post-bronchodilator spirometry showing FEV1/FVC ratio less than 0.70 and FEV1 between 30% and 70% of predicted normal
  • Chest X-ray or CT scan within 12 months showing no significant abnormalities unrelated to COPD
  • Either no maintenance therapy or stable use of LABA or LABA/ICS therapy for at least 60 days before consent
  • Ability to withhold short-acting bronchodilators before spirometry and maintain use of permitted maintenance therapy as required
  • Ability to correctly use the study jet nebulizer
  • Ability to perform acceptable spirometry according to ATS/ERS guidelines
  • Willingness and ability to attend all visits and comply with study assessments and procedures
Not Eligible

You will not qualify if you...

  • Presence of other significant pulmonary diseases besides COPD, such as asthma, tuberculosis, lung cancer, bronchiectasis, sarcoidosis, lung fibrosis, interstitial lung diseases, or uncontrolled sleep apnea
  • COPD exacerbation requiring hospitalization within 6 months before randomization
  • Use of oral or systemic therapies for COPD exacerbations within 3 months before randomization
  • History of life-threatening COPD requiring ICU admission or intubation
  • Severe comorbidities including unstable cardiac disease, NYHA class III or IV heart disease, or uncontrolled major medical conditions
  • Bladder outflow obstruction or catheterization within 6 months before randomization
  • History of narrow angle glaucoma
  • Hypersensitivity or intolerance to study drugs or related medications
  • History or current malignancy within 5 years except localized skin cancer
  • Significant psychiatric illness that prevents study completion
  • Clinically significant abnormal findings on physical exam, labs, or ECG
  • Prior or current use of ensifentrine (Ohtuvayre)
  • Lung resection or reduction surgery within 1 year before randomization
  • Long-term oxygen use over 12 hours per day
  • Pulmonary rehabilitation started or changed within 4 weeks before consent or planned changes during study
  • Major surgery within 6 weeks before randomization or incomplete recovery
  • History of drug or alcohol abuse within 5 years before randomization
  • Severe kidney impairment (eGFR less than 30 mL/min)
  • Elevated liver enzymes beyond specified limits
  • Use of experimental drugs or devices within 30 days before consent
  • Affiliation with the investigator site or family members of site staff

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 55 locations

1

SEC Clinical Research, LLC

Dothan, Alabama, United States, 36305-7375

Actively Recruiting

2

Elite Clinical Studies, LLC

Phoenix, Arizona, United States, 85018

Actively Recruiting

3

Downtown LA Research Center Inc - ClinEdge

Los Angeles, California, United States, 90017

Actively Recruiting

4

California Medical Research Associates, Inc.

Northridge, California, United States, 91324-6200

Actively Recruiting

5

Northern California Research Corp

Sacramento, California, United States, 95821-2640

Actively Recruiting

6

Clinical Research of West Florida Inc

Clearwater, Florida, United States, 33765

Actively Recruiting

7

Fleming Island Center For Clinical Research

Fleming Island, Florida, United States, 32003

Actively Recruiting

8

Florida Institute For Clinical Research LLC

Orlando, Florida, United States, 32825-4454

Actively Recruiting

9

Ormond Beach Clinical Research

Ormond Beach, Florida, United States, 32174-8196

Actively Recruiting

10

Progressive Medical Research

Port Orange, Florida, United States, 32127-5169

Actively Recruiting

11

Clinical Research of West Florida Inc - Tampa

Tampa, Florida, United States, 33606

Actively Recruiting

12

Centricity Research Columbus Georgia Multispecialty - PPDS

Columbus, Georgia, United States, 31904

Actively Recruiting

13

Southeast Lung Associates Research

Rincon, Georgia, United States, 31326

Withdrawn

14

ASHA Clinical Research - Hammond

Hammond, Indiana, United States, 46324

Actively Recruiting

15

Velocity Clinical Research - Valparaiso

Valparaiso, Indiana, United States, 46383

Actively Recruiting

16

Velocity Clinical Research (Rockville - Maryland) - PPDS

Rockville, Maryland, United States, 20854-2960

Actively Recruiting

17

Revive Research Institute, Inc

Southfield, Michigan, United States, 48075

Actively Recruiting

18

Midwest Chest Consultants PC

Saint Charles, Missouri, United States, 63301

Actively Recruiting

19

Midwest Clinical Research LLC

St Louis, Missouri, United States, 63141-7051

Actively Recruiting

20

The Clinical Research Center LLC - CRN

St Louis, Missouri, United States, 63141

Actively Recruiting

21

Sierra Clinical Research

Las Vegas, Nevada, United States, 89106

Terminated

22

Trialfinity Clinical Research Center

Hamilton, New Jersey, United States, 08619

Actively Recruiting

23

Horizon Family Medical Group - New Windsor Primary Care

New Windsor, New York, United States, 12553-7754

Actively Recruiting

24

American Health Research Inc

Charlotte, North Carolina, United States, 28277

Actively Recruiting

25

Clinical Research of Gastonia

Gastonia, North Carolina, United States, 28054-7481

Actively Recruiting

26

Stern Research Partners, LLC

Huntersville, North Carolina, United States, 28078

Actively Recruiting

27

Monroe Biomedical Research -343 Venus St

Monroe, North Carolina, United States, 28112-4025

Actively Recruiting

28

Carolina Research Center, Inc

Shelby, North Carolina, United States, 28150-3803

Actively Recruiting

29

Remington Davis Clinical Research

Columbus, Ohio, United States, 43215

Actively Recruiting

30

Advance Clinical Research

Kettering, Ohio, United States, 45439

Actively Recruiting

31

Clinical Research Associates of Central PA

DuBois, Pennsylvania, United States, 15801-2277

Actively Recruiting

32

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

33

Velocity Clinical Research - Anderson - PPDS

Anderson, South Carolina, United States, 29621-4822

Actively Recruiting

34

Pharmacorp Clinical Trials Incorporated

Charleston, South Carolina, United States, 29412

Actively Recruiting

35

Piedmont Research Partners LLC

Fort Mill, South Carolina, United States, 29707-4514

Actively Recruiting

36

Velocity Clinical Research - Gaffney - PPDS

Gaffney, South Carolina, United States, 29340-4737

Actively Recruiting

37

Lowcountry Lung and Critical Care PA

North Charleston, South Carolina, United States, 29406

Actively Recruiting

38

Monroe Biomedical Research Charleston

North Charleston, South Carolina, United States, 29406

Actively Recruiting

39

Clinical Research of Rock Hill

Rock Hill, South Carolina, United States, 29732

Actively Recruiting

40

Spartanburg Medical Research

Spartanburg, South Carolina, United States, 29303-4755

Actively Recruiting

41

Velocity Clinical Research

Spartanburg, South Carolina, United States, 29303

Actively Recruiting

42

Velocity Clinical Research - Union - PPDS

Union, South Carolina, United States, 29379

Actively Recruiting

43

Chattanooga Research & Medicine, PLLC

Chattanooga, Tennessee, United States, 37404

Actively Recruiting

44

ClinSearch - Chattanooga

Chattanooga, Tennessee, United States, 37421

Actively Recruiting

45

Clinical Trials Center of Middle Tennessee

Franklin, Tennessee, United States, 37067-5665

Actively Recruiting

46

MultiSpecialty Clinical Research, Inc

Johnson City, Tennessee, United States, 37604

Actively Recruiting

47

Inquest Clinical Research

Baytown, Texas, United States, 77521

Actively Recruiting

48

Corsicana Medical Research

Corsicana, Texas, United States, 75110-2471

Actively Recruiting

49

Horizon CR: Houston Pulmonary Sleep & Allergy Associates - Cypress - ClinEdge - PPDS

Cypress, Texas, United States, 77429

Actively Recruiting

50

Greater Heights Memorial Pulmonary and Sleep

Houston, Texas, United States, 77008

Actively Recruiting

51

Houston Pulmonary Medicine Associates, PA - Biopharma Informatic - PPDS

Houston, Texas, United States, 77089

Actively Recruiting

52

Huntsville Research Institute LLC

Huntsville, Texas, United States, 77340

Actively Recruiting

53

Element Research Group

San Antonio, Texas, United States, 78258

Actively Recruiting

54

Sherman Clinical Research - 403 N. Highland Ave

Sherman, Texas, United States, 75092

Actively Recruiting

55

Tranquil Clinical Research

Webster, Texas, United States, 77598-4085

Actively Recruiting

Loading map...

Research Team

V

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway Toll Free Number

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD | DecenTrialz